Skip to main content
. 2015 Nov 30;2015(11):CD011975. doi: 10.1002/14651858.CD011975

De Graaf 1999a.

Clinical features and settings High‐risk referral for invasive testing.
Participants 292 participants (207 participants before 14 weeks' gestation): 37 cases and 255 controls matched for maternal age (within 2 years), gestational age (within 2 weeks) and duration of sample storage (within 2 months)
The Netherlands ‐ single centre.
1994‐1997.
Pregnant women.
9‐15 weeks' gestation (in a few cases, blood samples for serum testing taken at 15‐19 weeks).
Study design Case‐control study.
Target condition and reference standard(s) Down's syndrome: 37 cases (30 affected pregnancies in women with serum testing enrolled before 14 weeks' gestation).
Reference standards: CVS or amniocentesis.
Index and comparator tests Maternal age.
First trimester NT (FMF methods) with cut off > 3 mm.
Frozen serum samples tested for:
First trimester free ßhCG and AFP (DELFIA dual labelled time resolved fluorescent assay).
First trimester serum PAPP‐A (DELFIA research assay (CR61‐105)).
First trimester serum AFP.
Follow‐up 100% karyotyping.
Aim of study To determine the expected detection rate and false positive rate for Down's syndrome achievable by early pregnancy screening with combined measurements of serum PAPP‐A, free beta hCG and fetal NT, with the addition of AFP.
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Selective testing of high‐risk women as done in practice. 
Acceptable reference standard? 
 All tests Yes Karyotyping.
Partial verification avoided? 
 All tests Yes All women had a reference standard.
Differential verification avoided? 
 All tests Yes All women had the same reference standard.
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test.
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of some index test results.
Index test results blinded? 
 All tests Unclear Unclear if all index tests interpreted without knowledge of reference standard results.
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice. 
Uninterpretable results reported? 
 All tests Yes Failed to measure NT in 11 control women.
Withdrawals explained? 
 All tests No No details of withdrawals given.